Chong-Xian Pan, MD; PhD

Adjunct Professor

  • 3552 Citations
  • 33 h-Index
19972021

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Chong-Xian Pan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

  • Research Output

    • 3552 Citations
    • 33 h-Index
    • 92 Article
    • 3 Review article
    • 1 Chapter

    Cytotoxic and chemosensitizing effects of glycoalkaloidic extract on 2D and 3D models using RT4 and patient derived xenografts bladder cancer cells

    Miranda, M. A., Marcato, P. D., Mondal, A., Chowdhury, N., Gebeyehu, A., Surapaneni, S. K., Bentley, M. V. L. B., Amaral, R., Pan, C. X. & Singh, M., Feb 2021, In : Materials Science and Engineering C. 119, 111460.

    Research output: Contribution to journalArticle

  • A simple three-dimensional in vitro culture mimicking the in vivo-like cell behavior of bladder patient-derived xenograft models

    Amaral, R., Zimmermann, M., Ma, A. H., Zhang, H., Swiech, K. & Pan, C. X., May 2020, In : Cancers. 12, 5, 1304.

    Research output: Contribution to journalArticle

    Open Access
  • Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer

    Long, Q., Ma, A. H., Zhang, H., Cao, Z., Xia, R., Lin, T. Y., Sonpavde, G. P., de Vere White, R., Guo, J. & Pan, C. X., Jan 1 2020, (Accepted/In press) In : Cancer Immunology, Immunotherapy.

    Research output: Contribution to journalArticle

  • Next-generation immuno-oncology agents: Current momentum shifts in cancer immunotherapy

    Pan, C., Liu, H., Robins, E., Song, W., Liu, D., Li, Z. & Zheng, L., Apr 3 2020, In : Journal of Hematology and Oncology. 13, 1, 29.

    Research output: Contribution to journalReview article

    Open Access
  • 6 Scopus citations

    Oxaliplatin-DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy

    Zimmermann, M., Li, T., Semrad, T. J., Wu, C. Y., Yu, A., Cimino, G., Malfatti, M., Haack, K., Turteltaub, K. W., Pan, C. X., Cho, M., Kim, E. J. & Henderson, P. T., Apr 1 2020, In : Molecular cancer therapeutics. 19, 4, p. 1070-1079 10 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations